Comparison of Cosmetic and Functional Outcome of Silicone Sheeting and Micro-needling on Hypertrophic Scars
Launched by FOUNDATION UNIVERSITY ISLAMABAD · Nov 3, 2021
Trial Information
Current as of April 24, 2025
Unknown status
Keywords
ClinConnect Summary
Hypertrophic scars and keloids are one of difficult conditions to treat. Prevention of abnormal scaring is more effective than treatment, so avoiding unnecessary wounds in patients is a solution but flawed one. Many treatment options are presented over time, but most of the treatments remain insufficient. Treatment options include massage therapy, silicone sheet, occlusive dressings, pressure garments, adhesive tape, intra-lesional steroid injections, laser therapy, cryotherapy, radiotherapy, 5-fluorouracil, interferons, bleomycin, imiquimod 5%cream, tranilast, botulin toxin and surgical ex...
Gender
ALL
Eligibility criteria
- • 1. All the patients presenting with hypertrophic scars ≥1cm in size
- • 2. Any age
- • 3. Both genders
- Exclusion criteria:
- • 1. Pregnant or lactating mothers
- • 2. Patients who already taking systemic steroid as confirmed through clinical record
- • 3. Patients with renal failure or liver failure as confirmed through clinical history
- • 4. Patient with uncontrolled diabetes.
- • 5. Patients who received treatment for keloids or hypertrophic scar in past.
- • 6. Patients with active inflammation in area of hypertrophic scar or in its vicinity.
About Foundation University Islamabad
Foundation University Islamabad (FUI) is a prominent educational institution dedicated to advancing research and innovation in various fields, including clinical sciences. With a commitment to excellence in education and healthcare, FUI fosters a collaborative environment that encourages multidisciplinary research initiatives. The university actively engages in clinical trials aimed at improving patient outcomes and contributing valuable insights to the medical community. Through its state-of-the-art facilities and a team of experienced professionals, Foundation University Islamabad strives to uphold the highest ethical standards in clinical research, ensuring the integrity and reliability of its findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, Federal, Pakistan
Rawalpindi, Punjab, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials